Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05329493 · ClinicalTrials.gov registry record · NA

A Novel Cooling Device for Pain Management During Fingerstick Blood Draw

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
6
Enrollment target

NCT05329493: Completed NA study, sponsored by Massachusetts General Hospital.

NCT05329493 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05329493, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

In this study, the investigators seek to evaluate a novel tissue-cooling device for pain management during needle sticks and /or blood draw on the fingertips.

Primary Outcome

This scale will be used to record subject pain from the overall pain from the procedure for the treatment and control finger. There are 6 faces ranging from 0 no hurt to 10 hurts the worst.

Interventions

  • DEVICE Cooling digit device application

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2023-06-21
Est. Completion 2024-11-08
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT05329493 record still lists

NCT05329493 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Cooling digit device application is the first listed.

NCT05329493 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05329493 about?

NCT05329493 is a clinical study titled "A Novel Cooling Device for Pain Management During Fingerstick Blood Draw". In this study, the investigators seek to evaluate a novel tissue-cooling device for pain management during needle sticks and /or blood draw on the fingertips.

What is the current status of trial NCT05329493?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2023-06-21. Estimated completion is 2024-11-08.

What interventions are being tested in trial NCT05329493?

The interventions under investigation include: Cooling digit device application (DEVICE).

Who is sponsoring clinical trial NCT05329493?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05329493's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05329493, the US trial registry maintained by the National Library of Medicine. NCT05329493 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.